Start Date
July 31, 2020
Primary Completion Date
August 5, 2020
Study Completion Date
August 5, 2020
KZR-616
Patients will receive KZR-616 SC once weekly. Patients assigned to Arm A will receive 30 mg for 13 weeks and patients assigned to Arm B will receive 30 mg for 1 week then 45 mg for 12 weeks
KZR Research Site, The Bronx
KZR Research Site, Greenville
KZR Research Site, Jacksonville
KZR Research Site, Miami Lakes
KZR Research Site, Tampa
KZR Research Site, Columbus
KZR Research Site, Cleveland
KZR Research Site, Minneapolis
KZR-616 Research Site, Rochester
KZR Research Site, Peoria
KZR Research Site, Webster
KZR Research Site, Los Angeles
KZR Research Site, San Francisco
KZR Research Site, Boston
KZR Research Site, Morristown
KZR Research Site, Woolloongabba
KZR Research Site, Bologna
KZR Research Site, Genova
KZR Research Site, Krakow
KZR Research Site, Poznan
KZR Research Site, Moscow
KZR Research Site, Saint Petersburg
Lead Sponsor
Kezar Life Sciences, Inc.
INDUSTRY